[Inidications for multivalve prostheses].

A Jouve; J Houel; C l Malmejac; Y Baille; D Metras; H Escojido; A Rapuzzi; J C Jouven

Home/Archive/PubMed

PubMed · 823909

[Inidications for multivalve prostheses].

A Jouve·J Houel·C l Malmejac·Y Baille·D Metras·H Escojido·A Rapuzzi·J C Jouven

View original source ↗Export metadata ↓

Abstract

The authors consider that the indications for surgery should take into account three unknowns: the natural history of the valvulopathies, our incomplete state of knowledge about the outcome in operated cases, and surgical progress, which may transform the whole subject in a short time. They emphasize the seriousness of the disorders in which mitral incompetence is associated with aortic stenosis and/or incompetence; such cases justify earlier surgery. By contrast, some cases of aortic incompetence, when associated with a predominant mitral valve lesion, may not constitute an indication for valve replacement. Tricuspid annuloplasty is a noteworthy advance which provides a simple answer to some of the problems.

Explore related subjects

Aortic Valve Aortic Valve Insufficiency Aortic Valve Stenosis Heart Valve Prosthesis Humans Mitral Valve Mitral Valve Insufficiency Mitral Valve Stenosis Risk English Abstract Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

A Jouve, J Houel, C l Malmejac, Y Baille, D Metras, H Escojido, A Rapuzzi, J C Jouven. 1976. [Inidications for multivalve prostheses].. https://pubmed.ncbi.nlm.nih.gov/823909/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Aortic valve sclerosis as a marker of active atherosclerosis.

Aortic sclerosis is a calcific disease of the aortic valvular leaflets defined as focal leaflet thickening without significant obstruction to left ventricular outflow. Several clinical factors are associated with calcific aortic valve disease, including male sex, smoking, hypertension, age, hypercholesterolemia, and diabetes. Histologic and biochemical studies suggest similarities between the mechanisms involved in the development of aortic sclerosis and atherosclerosis, suggesting these two diseases may share common pathophysiologic mechanisms. In a recent prospective trial, the presence of aortic sclerosis was associated with an approximately 50% increase in cardiovascular mortality and myocardial infarction, even after correction for age, gender, known coronary artery disease, and clinical factors associated with a aortic sclerosis.

Aortic Valve↗

PubMed2002

Enlargement of the aortic annulus using a double-patch technique: a safe and effective method.

We have tested a new method to enlarge the aortic annulus using a double-patch technique after the Manouguian principle. Our study included 14 patients who had no operative mortality and no complications; long-term follow-up was 13 years. The method prevented mitral insufficiency and operative bleeding at the aortic root.

Aortic Valve↗

PubMed2002

Paravalvular leak and other events in silzone-coated mechanical heart valves: a report from AVERT.

BACKGROUND: The Artificial Valve Endocarditis Reduction Trial (AVERT) was designed to compare endocarditis rates in Silzone versus conventional valves. Recruitment ended January 21, 2000, because of higher rates of paravalvular leakage in patients receiving the Silzone prosthesis. The present analysis determined late event rates that might be used in the management of approximately 36,000 patients who have received the Silzone prosthesis. METHODS: A total of 807 patients in 19 centers in North America and Europe were randomized. Mean age was 61+/-11 years; 41% were women. Operations included aortic valve replacement in 59%, mitral valve replacement in 32%, and aortic and mitral valve replacements in 9%; 41% had concomitant operations (26% coronary artery bypass grafting). RESULTS: Major paravalvular leakage (followed by repair, explant, or mortality) occurred in 18 of 403 patients receiving Silzone valves and 4 of 404 patients without Silzone valves (2-year event-free rates: 91.1% versus 98.9% conventional, p < 0.003). Similarly, 2-year freedom from any explant was lower in the Silzone arm (19 versus 2 events; 90.1% versus 99.4%, p = 0.0002). Rates of mortality and stroke were similar during follow-up. CONCLUSIONS: Continued follow-up of AVERT supports the conclusion that the Silzone prosthesis has increased risk of paravalvular leakage requiring reoperation. Overall survival is similar in the two groups.

Aortic Valve↗